Literature DB >> 17893114

Cognitive abilities as predictors of safety to drive in people with multiple sclerosis.

N B Lincoln1, K A Radford.   

Abstract

Cognitive impairments resulting from multiple sclerosis (MS) may affect driving performance. The purpose was to determine whether cognitive tests predict safety to drive in people with MS. Participants were recruited from people referred to Derby Regional Mobility Centre for assessment of their fitness to drive. They were assessed on tests of cognitive abilities related to driving including: the Stroke Drivers Screening Assessment, Paced Auditory Serial Addition Test, Stroop, Motor Impersistence and Adult Memory and Information Processing Battery (AMIPB). Participants' safety to drive on the public road was tested by an approved driving instructor blind to the results of the cognitive assessment. There were 34 participants with MS, 17 were men, mean age 46 (SD 10.4) years. Safe and unsafe drivers were compared. Significant differences were found on tests of executive function (Road Sign Recognition, P<0.01), visual memory (Design Learning Interference, P<0.05) Information Processing (AMIPB Task A, P<0.05 and B, P<0.05), concentration (Dot Cancellation false positive errors, P<0.01) and visuospatial abilities (AMIPB Figure copy). An equation was generated using discriminant function analysis with an overall predictive accuracy of 88% (Sensitivity for pass 90%, Specificity 90%). Cognitive abilities were predictors of safety to drive in people with MS.

Entities:  

Mesh:

Year:  2007        PMID: 17893114     DOI: 10.1177/1352458507080467

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

1.  Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.

Authors:  Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant
Journal:  Aust N Z J Psychiatry       Date:  2012-02       Impact factor: 5.744

2.  Prediction of driving ability in people with relapsing-remitting multiple sclerosis using the stroke driver screening assessment.

Authors:  Abiodun Emmanuel Akinwuntan; Christina O'Connor; Erin McGonegal; Kristen Turchi; Suzanne Smith; Mitzi Williams; Jerry Wachtel
Journal:  Int J MS Care       Date:  2012

Review 3.  Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies.

Authors:  Klaus G Petry; Bruno Brochet; Vincent Dousset; Jean Rodolphe Vignes; Claudine Boiziau
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

4.  Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial.

Authors:  Delphine Van Laethem; Frederik Van de Steen; Daphne Kos; Maarten Naeyaert; Peter Van Schuerbeek; Miguel D'Haeseleer; Marie B D'Hooghe; Jeroen Van Schependom; Guy Nagels
Journal:  Trials       Date:  2022-09-14       Impact factor: 2.728

5.  Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.

Authors:  Mark Gudesblatt; Karl Wissemann; Myassar Zarif; Barbara Bumstead; Lori Fafard; Jeffrey Wilken; Karen Blitz; Marijean Buhse; Sourav Santra; Christophe Hotermans; Lily Lee
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.